Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Delic Hldgs Corp (OP: DELCF )

0.0038 UNCHANGED
Streaming Delayed Price Updated: 1:54 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,500
Open 0.0037
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0038
Today's Range 0.0037 - 0.0038
52wk Range 0.0012 - 0.0649
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EU Parliament Unveils Working Group to Advance Medical Psychedelics
Via Investor Brand Network
NIDA Avails $1.5M for Research on Drug Addiction Treatment Using Psychedelics
Via Investor Brand Network

Performance

YTD
-90.10%
-90.10%
1 Month
-25.49%
-25.49%
3 Month
-85.55%
-85.55%
6 Month
-86.76%
-86.76%
1 Year
-91.48%
-91.48%

More News

Read More
Beckley Psytech Commences Phase 2a Trial for Treatment-Resistant Depression
Via Investor Brand Network
Study Looks into Neurobiology of Psychedelics
Via Investor Brand Network
Challenges Facing European Psychedelics Industry
Via Investor Brand Network
US Doctors Could Prescribe MDMA in 2024
Via Investor Brand Network
Psychedelic-Assisted Therapy May Soon Gain Accreditation Standards
Via Investor Brand Network
Topics Religion
Exposures Religion
PsychedelicNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Inks LOI for Acquisition of Ketamine Wellness Centers
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Delic Holdings Corp. Signs LOI with Peter/PetraMD to Acquire Ketamine Wellness Centers and Facilitate Online Ketamine Treatments Nationwide
From Delic Holdings Corp.
Via Business Wire
Massachusetts Legislator Files Bill Capping MDMA Therapy Costs
Via Investor Brand Network
Committee Formed to Rally Political Candidates Who Support Therapeutic Psychedelic Use
Via Investor Brand Network
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Via Benzinga
Oklahoma House Passes Bill Promoting Psychedelics Research, Patient Protection
Via Investor Brand Network
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Via Benzinga
Risks of Buying Psilocybin Mushrooms from Online Suppliers
Via Investor Brand Network
Combining VR, Psychedelics May Be Effective Therapy
Via Investor Brand Network
New Study Finds That Psilocybin Creates Strong Ties to Nature in Users
Via Investor Brand Network
Study Links Use of Classic Psychedelics to Positive Behaviors
Via Investor Brand Network
Study Looks into Effects of Hallucinogenic Mushrooms on Bipolar Disorder
Via Investor Brand Network
Nonprofit in Oregon Launches Training Program for Psilocybin Facilitators
Via Investor Brand Network
Ketamine, Smiling Faces Combo Hold Promise in Treating Depression
Via Investor Brand Network
Schools Step Up Training for Psychedelic Therapy Professionals
Via Investor Brand Network
Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month
Via Talk Markets
Christmas As We Know It May Be Based On Psychedelic Traditions
Via Investor Brand Network
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.